SlideShare a Scribd company logo
1 of 19
Download to read offline
https://www.creative-biolabs.com/complement-therapeutics/
COMPLEMENT
THERAPEUTICS
Creative Biolabs offers comprehensive one-stop
services for complement therapeutics.
Creative Biolabs is a leading service provider in the complement
therapeutics field in the US. Our one-stop drug discovery platforms
and experienced technicians are dedicated in helping you develop
therapeutic candidates, diagnostic reagents…
We provide a broad portfolio of laboratory and manufacturing
services for complement therapeutic:
About Us
For more than 10 years,
we have been providing
the best services,
products and
communications to our
valuable customers based
on the values of quality,
timing and price.
٠ Therapeutic Antibodies
٠ Protein Antigens
٠ Soluble Complement Regulators
٠ Serine Protease Inhibitors
٠ Complement Component Inhibitors
٠ Anaphylatoxin Receptor Antagonists
…
Outline
C O M P L E M E N T T H E R A P E U T I C S
01
With the belief of the
customer-first principle,
we serve our global
clients with the most
reliable and qualified
results.
Introduction Indication
Services Products
2011
Classical pathway involves
complement components
C1, C2 and C4, and is
triggered by antibody-
antigen complexes binding
to C1.
Alternative pathway
involves various factors, B,
D, H & I, and is initiated by
cell surface constituents
that are foreign to the
host.
Lectin pathway is
activated by the binding
of mannose-binding lectin
(MBL) to mannose
residues on the pathogen
surface.
Complement System Introduction
C O M P L E M E N T T H E R A P E U T I C S
Complement is a system of plasma proteins that can
be activated directly by pathogens or indirectly by
pathogen-bound antibody, leading to a cascade of
reactions that occur on the surface of pathogens
and generate active components with various
effector functions.
02
Complement Pathways
Classical
Pathway
Alternative
Pathway
Lectin
Pathway
Fig.1 Complement cascade. (Mathern, 2015)
Activation Regulation
Homeostasis
Too much activation/
Insufficient regulation
Too much regulation/
Insufficient activation
Infection
Inflammation
The intricate complement network requires rigorous regulation to maintain appropriate
homeostasis.
Complement System Regulation
C O M P L E M E N T T H E R A P E U T I C S
03
Cardiovascular Disease
Autoimmune Disease Nephropathy
Osteology
Genetic Disease
Infection
Neurology
Inflammatory Disease Ophthalmology
Excessive or insufficient activation will break the delicate balance
between complement activation and regulation, leading to a variety
of diseases.
Creative Biolabs provides a great variety of therapeutic antibodies,
inhibitors, soluble complement regulators, as well as customized
services to help our customer develop novel drugs for complement-
related diseases.
Complement Therapeutics Indication
C O M P L E M E N T T H E R A P E U T I C S
Complement-related Diseases
Complement Therapeutics
04
Technicians in Creative Biolabs’s experienced team provide complement therapeutic services ranging from therapeutic antibody, protease inhibitor, soluble complement
regulator, complement component inhibitor to anaphylatoxin receptor antagonist development. We help our clients discover novel drugs, avoid the pitfalls of variability in
assays and benefit from the efficiency and accuracy of a dedicated facility.
Complement Therapeutics Service
C O M P L E M E N T T H E R A P E U T I C S
05
Serine Protease Inhibitors Soluble Complement Regulators
Therapeutic Antibodies Complement Component Inhibitors
Anaphylatoxin Receptor Antagonists
• C5 Antibody Development
• CD46 (MCP) Antibody Development
• CD59 (MIRL) Antibody Development
• CD20 Antibody Development
• CD55 (DAF) Antibody Development
…
Antibody-based therapeutics appears to be the most rapidly growing
drug class against complement-related diseases. Based on the advanced
technology and rich experience, Creative Biolabs offers a comprehensive
service of therapeutic antibodies development for our clients.
OUR THERAPEUTIC ANTIBODY
DEVELOPMENT SERVICE INCLUDES:
Therapeutic Antibody Development
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Service
A natural panel of highly effective complement regulators that primarily
act at the level of convertases or the terminal complement complex (TCC)
can be exploited for therapeutic purposes. We have developed an
advanced platform of soluble complement regulators services to support
your projects. Our soluble complement regulators services can be tailor-
designed to meet your specific needs and it is fast, reliable and affordable.
OUR SOLUBLE COMPLEMENT REGULATOR
DEVELOPMENT SERVICE INCLUDES:
• sCR1/TP10 Development Service
• CAB-2/MLN-2222 Development Service
• C4-binding Protein (C4BP) Development Service
• Factor H Development Service
• Factor I Development Service
…
Soluble Complement Regulator Development
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Service
Inappropriate activation or regulation of complement cascade may be
destructive for host cells and is involved in lots of diseases and pathological
conditions. Modulation or inhibition of complement activity has therefore
been regarded as a promising diagnostic or therapeutic strategy. Creative
Biolabs is proud to offer a range of complement component inhibitors
development services in a timely and cost-effective manner.
OUR COMPLEMENT COMPONENT
INHIBITOR DEVELOPMENT SERVICE
INCLUDES:
• Compstain
• Aptamer
…
Complement Component Inhibitor Development
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Service
Complement systems are proteolytic cascades in which serine proteases are
activated from each other by limited proteolysis in a strictly ordered manner.
Inhibition of the complement serine proteases may be an attractive therapeutic
approach. As one of the most highly respected drug discovery and antibody
development companies, Creative Biolabs provides biotherapeutics development
strategies for serine protease inhibitors including serpins, macroglobulins, and
other small protein inhibitors.
OUR SERINE PROTEASE INHIBITOR
DEVELOPMENT SERVICE INCLUDES:
• Serpins Development Service
• Macroglobulins Development Service
• Small Protein Inhibitors Development Service
…
Serine Protease Inhibitor Development
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Service
Anaphylatoxins, or complement peptides, are fragments that are produced
as part of the activation of the complement system. Complement protein
C5a and C3a are the most common targets of inhibition against various
diseases and the antagonists for C5aR and C3aR have been explored as
therapeutic intervention in many diseases. Creative Biolabs provides
anaphylatoxin receptor antagonist development services against a variety
of complement component.
OUR ANAPHYLATOXIN RECEPTOR
ANTAGONIST DEVELOPMENT SERVICE
INCLUDES:
• PMX53
• SB290157
…
Anaphylatoxin Receptor Antagonist Development
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Service
05
Inhibitors
• High affinity
• High specificity
• Wide applications
• High potency
• Standardized
transportation
• Customizable
…
• Safe
• High efficiency
• Quality control
• Ready to use
• Universality
• Customizable
…
• High specificity and
sensitivity
• Quick and accurate
results
• Easily automated
• Convenient and easy-
to-use
• Low false-positive
rate
• Customizable
…
• Guaranteed quantity
• Fast synthesis
• High specificity
• User-friendly
presentation
• Customizable
…
• High purity
• High solubility
• Wide applications
• Mimetic function
• Standardized
transportation
• Customizable
…
Complement Therapeutics Products
C O M P L E M E N T T H E R A P E U T I C S
06
01
Antibodies
02
Proteins
03
Peptides
04
Assay Kits
05
Inhibitors
Creative Biolabs offers a series of ready-to-use antibodies targeting different components of the complement system.
These antibodies with good sensitivity and specificity are available for WB, Flow, Func, IA, ICC/IF, IHC, IHC-Fr. We
believe that our high-quality antibodies can assist your research and development project of the complement system.
Product Name Specie Reactivity Applications
Anti-Complement Component C1qA Monoclonal Antibody Human WB; Flow; Func; IA; ICC/IF; IHC
Anti-Complement Component C1r Monoclonal Antibody Human WB; IP
Anti-Complement Component C2 Monoclonal Antibody Human WB; IP; ELISA
Anti-Complement Component C3 Monoclonal Antibody Human ELISA; IF; IHC; WB
Anti-Complement Component C4 Monoclonal Antibody Human ELISA; WB
Anti-Complement Component C5 Monoclonal Antibody Human ELISA; WB
Anti-Complement Component C6 Monoclonal Antibody Human ELISA; Flow; IHC; IHC-Fr
Anti-Complement Component C7 Monoclonal Antibody Human WB; ELISA
Featured antibodies for complement therapeutics:
ANTIBODIES
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Products
Creative Biolabs provides a variety of complement system-related proteins, which could be the qualified tools for
the early discovery process in life science research and groundbreaking development of specific clinical
applications. These proteins with high purity and solubility are available for WB, ELISA, PA, AP, etc.
Product Name Applications
Recombinant Human C1QB Protein-GST tag WB; ELISA; PA; AP
Recombinant Mouse C1qBP Protein-6His tag Binding Activity Assays
Recombinant Human Complement Component C1qC Protein-GST tag WB; ELISA; PA; AP
Recombinant Human C1QL1 Protein-GST tag AP; Array; ELISA; WB
Recombinant Human Complement Factor H-related 5 Protein-10His tag Bioactivity Assays
Recombinant Mouse Complement Factor P Protein-His tag WB; ELISA; IP
Recombinant Human Complement C3 Protein-GST tag WB; ELISA; PA; AP
Featured proteins for complement therapeutics:
Complement
Therapeutics
Products
PROTEINS
C O M P L E M E N T T H E R A P E U T I C S
Creative Biolabs provides a wide range of array kits that are considered as particularly powerful tools for studying
disease pathways, screening for potential drug candidates and evaluating biopharmaceutical production processes.
These specific array kits can detect new receptors or targets in various diseases, assess protein-protein interactions,
to quantitate the amount of target analytes or monitor protein expression levels in biological samples.
Product Name Pack Size
Human Complement C3a des Arg ELISA Kit 96 wells
Human Complement C4a des Arg ELISA Kit 96 wells
Human Complement C5a AccuSignal ELISA Kit 96 wells
Human Complement C3 ELISA Kit 96 wells
Human Complement C1q ELISA Kit 96 wells
Human Complement C1R ELISA Kit 96 wells
Human Complement C2 ELISA Kit 96 wells
Featured array kits for complement therapeutics:
ARRAY KITS
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Products
Peptides are synthesized naturally from transcription of DNA and they perform a wide range of essential
functions in all manner of biological processes. Creative Biolabs provides the customers with many kinds of
different premade complement associated peptides, from which you can easily choose an optimal candidate to
help you get a milestone development.
Product Name Applications
Glutamic acid decarboxylase mAb (11) Blocking Peptide IHC; WB
Glutamic acid decarboxylase pAb Blocking Peptide IHC; WB
Heme oxygenase 1 pAb Blocking Peptide Elisa; WB
Heme oxygenase 2 pAb Blocking Peptide Elisa; WB
Complement C1q Binding Protein (CD93) Peptide ELISA; WB; IP; IHC; ICC
Complement C2 Blocking Peptide IHC; WB
Complement C1QB Blocking Peptide Blocking
Featured peptides for complement therapeutics:
PEPTIDES
C O M P L E M E N T T H E R A P E U T I C S
Complement
Therapeutics
Products
Why Us
• 10 years+ of exploration & development
• Full range of one-stop services for Complement Therapeutics
• Fully customizable project procedure
• Your best partner in Complement-based Drug Discovery
Service Features
• Extensive experience and advanced biotechnologies
• Fully customizable experimental design to meet your R&D timeline and budget
• Competitive price with the best quality
• Best after-sale service
07 Our Advantages
Contact Us
USA HQ Mailing Address:
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-466-5530
Fax: 1-631-207-8356
Email: info@creative-biolabs.com
Quality / Science / Dedication

More Related Content

Similar to Complement Therapeutics_Creative Biolabs

(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_BrochureJane Hibberd
 
My fit line_product-catalogue
My fit line_product-catalogueMy fit line_product-catalogue
My fit line_product-catalogueKsenia Ejhler
 
1 cn services_overall_brochure
1 cn services_overall_brochure1 cn services_overall_brochure
1 cn services_overall_brochureHajira Ghani
 
Protein Formulation Development
Protein Formulation DevelopmentProtein Formulation Development
Protein Formulation DevelopmentIntegrity Bio
 
SMi Group's 9th annual ADMET conference & exhibition
SMi Group's 9th annual ADMET conference & exhibitionSMi Group's 9th annual ADMET conference & exhibition
SMi Group's 9th annual ADMET conference & exhibitionDale Butler
 
LucyBaker_portfolio
LucyBaker_portfolioLucyBaker_portfolio
LucyBaker_portfolioLucy Baker
 
Anaquant-Protein quantitation by mass spectrometry
Anaquant-Protein quantitation by mass spectrometryAnaquant-Protein quantitation by mass spectrometry
Anaquant-Protein quantitation by mass spectrometryAnaQuant
 
KO-brochure-online-jan2015-hi
KO-brochure-online-jan2015-hiKO-brochure-online-jan2015-hi
KO-brochure-online-jan2015-hiSteve Brough
 
Aptamer development-platform
Aptamer development-platformAptamer development-platform
Aptamer development-platformShawVivian
 
P-173 CTL new spex added 100516
P-173 CTL new spex added 100516P-173 CTL new spex added 100516
P-173 CTL new spex added 100516Kiran Bains
 
Adherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptxAdherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptxGenScript ProBio
 
QPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS Holdings, LLC
 
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Fight Colorectal Cancer
 

Similar to Complement Therapeutics_Creative Biolabs (20)

(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
 
Mtr corporate
Mtr corporateMtr corporate
Mtr corporate
 
Revive Brochure
Revive BrochureRevive Brochure
Revive Brochure
 
My fit line_product-catalogue
My fit line_product-catalogueMy fit line_product-catalogue
My fit line_product-catalogue
 
1 cn services_overall_brochure
1 cn services_overall_brochure1 cn services_overall_brochure
1 cn services_overall_brochure
 
Protein Formulation Development
Protein Formulation DevelopmentProtein Formulation Development
Protein Formulation Development
 
Bhat Bio Tech India Pvt.Ltd.
Bhat Bio Tech India Pvt.Ltd.Bhat Bio Tech India Pvt.Ltd.
Bhat Bio Tech India Pvt.Ltd.
 
SMi Group's 9th annual ADMET conference & exhibition
SMi Group's 9th annual ADMET conference & exhibitionSMi Group's 9th annual ADMET conference & exhibition
SMi Group's 9th annual ADMET conference & exhibition
 
LucyBaker_portfolio
LucyBaker_portfolioLucyBaker_portfolio
LucyBaker_portfolio
 
Protein characterization
Protein characterization Protein characterization
Protein characterization
 
Enzo capabilities brochure
Enzo capabilities brochureEnzo capabilities brochure
Enzo capabilities brochure
 
Anaquant-Protein quantitation by mass spectrometry
Anaquant-Protein quantitation by mass spectrometryAnaquant-Protein quantitation by mass spectrometry
Anaquant-Protein quantitation by mass spectrometry
 
KO-brochure-online-jan2015-hi
KO-brochure-online-jan2015-hiKO-brochure-online-jan2015-hi
KO-brochure-online-jan2015-hi
 
Aptamer development-platform
Aptamer development-platformAptamer development-platform
Aptamer development-platform
 
Stabicon Business Portfolio
Stabicon Business PortfolioStabicon Business Portfolio
Stabicon Business Portfolio
 
P-173 CTL new spex added 100516
P-173 CTL new spex added 100516P-173 CTL new spex added 100516
P-173 CTL new spex added 100516
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
Adherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptxAdherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptx
 
QPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large Molecules
 
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
 

More from CandySwift_NY

Exosomes Biogenesis&Therapeutics
Exosomes Biogenesis&TherapeuticsExosomes Biogenesis&Therapeutics
Exosomes Biogenesis&TherapeuticsCandySwift_NY
 
Genome Editing Introduction
Genome Editing IntroductionGenome Editing Introduction
Genome Editing IntroductionCandySwift_NY
 
Oncolytic Virus and Immunotherapy
Oncolytic Virus and ImmunotherapyOncolytic Virus and Immunotherapy
Oncolytic Virus and ImmunotherapyCandySwift_NY
 
Introduction of SARS-CoV-2
Introduction of SARS-CoV-2Introduction of SARS-CoV-2
Introduction of SARS-CoV-2CandySwift_NY
 
SARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative BiolabsSARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative BiolabsCandySwift_NY
 
SARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative BiolabsSARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative BiolabsCandySwift_NY
 
Anti dengue-virus-antibody-products-and-services
Anti dengue-virus-antibody-products-and-servicesAnti dengue-virus-antibody-products-and-services
Anti dengue-virus-antibody-products-and-servicesCandySwift_NY
 
The development of oncolytic viruses—Creative Biolabs
The development of oncolytic viruses—Creative BiolabsThe development of oncolytic viruses—Creative Biolabs
The development of oncolytic viruses—Creative BiolabsCandySwift_NY
 
Introduction to SARS-CoV-2-Creative Biolabs
Introduction to SARS-CoV-2-Creative BiolabsIntroduction to SARS-CoV-2-Creative Biolabs
Introduction to SARS-CoV-2-Creative BiolabsCandySwift_NY
 
Creative biolabs.cart nk cell-based-therapeutics
Creative biolabs.cart nk cell-based-therapeuticsCreative biolabs.cart nk cell-based-therapeutics
Creative biolabs.cart nk cell-based-therapeuticsCandySwift_NY
 
oncolytic virus immunotherapy
oncolytic virus immunotherapyoncolytic virus immunotherapy
oncolytic virus immunotherapyCandySwift_NY
 
The development of oncolytic viruses
The development of oncolytic virusesThe development of oncolytic viruses
The development of oncolytic virusesCandySwift_NY
 
Oncolytic virus immunotherapy
Oncolytic virus immunotherapyOncolytic virus immunotherapy
Oncolytic virus immunotherapyCandySwift_NY
 
oncolytic herpes simplex virus
oncolytic herpes simplex virusoncolytic herpes simplex virus
oncolytic herpes simplex virusCandySwift_NY
 
Immunogenicity manipulation
Immunogenicity manipulationImmunogenicity manipulation
Immunogenicity manipulationCandySwift_NY
 
Oncolytic virus basis
Oncolytic virus basisOncolytic virus basis
Oncolytic virus basisCandySwift_NY
 
Exosome applications
Exosome applications Exosome applications
Exosome applications CandySwift_NY
 

More from CandySwift_NY (18)

SARS-CoV-2 Vaccines
SARS-CoV-2 VaccinesSARS-CoV-2 Vaccines
SARS-CoV-2 Vaccines
 
Exosomes Biogenesis&Therapeutics
Exosomes Biogenesis&TherapeuticsExosomes Biogenesis&Therapeutics
Exosomes Biogenesis&Therapeutics
 
Genome Editing Introduction
Genome Editing IntroductionGenome Editing Introduction
Genome Editing Introduction
 
Oncolytic Virus and Immunotherapy
Oncolytic Virus and ImmunotherapyOncolytic Virus and Immunotherapy
Oncolytic Virus and Immunotherapy
 
Introduction of SARS-CoV-2
Introduction of SARS-CoV-2Introduction of SARS-CoV-2
Introduction of SARS-CoV-2
 
SARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative BiolabsSARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative Biolabs
 
SARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative BiolabsSARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative Biolabs
 
Anti dengue-virus-antibody-products-and-services
Anti dengue-virus-antibody-products-and-servicesAnti dengue-virus-antibody-products-and-services
Anti dengue-virus-antibody-products-and-services
 
The development of oncolytic viruses—Creative Biolabs
The development of oncolytic viruses—Creative BiolabsThe development of oncolytic viruses—Creative Biolabs
The development of oncolytic viruses—Creative Biolabs
 
Introduction to SARS-CoV-2-Creative Biolabs
Introduction to SARS-CoV-2-Creative BiolabsIntroduction to SARS-CoV-2-Creative Biolabs
Introduction to SARS-CoV-2-Creative Biolabs
 
Creative biolabs.cart nk cell-based-therapeutics
Creative biolabs.cart nk cell-based-therapeuticsCreative biolabs.cart nk cell-based-therapeutics
Creative biolabs.cart nk cell-based-therapeutics
 
oncolytic virus immunotherapy
oncolytic virus immunotherapyoncolytic virus immunotherapy
oncolytic virus immunotherapy
 
The development of oncolytic viruses
The development of oncolytic virusesThe development of oncolytic viruses
The development of oncolytic viruses
 
Oncolytic virus immunotherapy
Oncolytic virus immunotherapyOncolytic virus immunotherapy
Oncolytic virus immunotherapy
 
oncolytic herpes simplex virus
oncolytic herpes simplex virusoncolytic herpes simplex virus
oncolytic herpes simplex virus
 
Immunogenicity manipulation
Immunogenicity manipulationImmunogenicity manipulation
Immunogenicity manipulation
 
Oncolytic virus basis
Oncolytic virus basisOncolytic virus basis
Oncolytic virus basis
 
Exosome applications
Exosome applications Exosome applications
Exosome applications
 

Recently uploaded

Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...apidays
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...Zilliz
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusZilliz
 
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelNavi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelDeepika Singh
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businesspanagenda
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoffsammart93
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Miguel Araújo
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherRemote DBA Services
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProduct Anonymous
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?Igalia
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Scriptwesley chun
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)wesley chun
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century educationjfdjdjcjdnsjd
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobeapidays
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdflior mazor
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 

Recently uploaded (20)

Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source Milvus
 
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelNavi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 

Complement Therapeutics_Creative Biolabs

  • 2. Creative Biolabs is a leading service provider in the complement therapeutics field in the US. Our one-stop drug discovery platforms and experienced technicians are dedicated in helping you develop therapeutic candidates, diagnostic reagents… We provide a broad portfolio of laboratory and manufacturing services for complement therapeutic: About Us For more than 10 years, we have been providing the best services, products and communications to our valuable customers based on the values of quality, timing and price. ٠ Therapeutic Antibodies ٠ Protein Antigens ٠ Soluble Complement Regulators ٠ Serine Protease Inhibitors ٠ Complement Component Inhibitors ٠ Anaphylatoxin Receptor Antagonists …
  • 3. Outline C O M P L E M E N T T H E R A P E U T I C S 01 With the belief of the customer-first principle, we serve our global clients with the most reliable and qualified results. Introduction Indication Services Products
  • 4. 2011 Classical pathway involves complement components C1, C2 and C4, and is triggered by antibody- antigen complexes binding to C1. Alternative pathway involves various factors, B, D, H & I, and is initiated by cell surface constituents that are foreign to the host. Lectin pathway is activated by the binding of mannose-binding lectin (MBL) to mannose residues on the pathogen surface. Complement System Introduction C O M P L E M E N T T H E R A P E U T I C S Complement is a system of plasma proteins that can be activated directly by pathogens or indirectly by pathogen-bound antibody, leading to a cascade of reactions that occur on the surface of pathogens and generate active components with various effector functions. 02 Complement Pathways Classical Pathway Alternative Pathway Lectin Pathway
  • 5. Fig.1 Complement cascade. (Mathern, 2015) Activation Regulation Homeostasis Too much activation/ Insufficient regulation Too much regulation/ Insufficient activation Infection Inflammation The intricate complement network requires rigorous regulation to maintain appropriate homeostasis. Complement System Regulation C O M P L E M E N T T H E R A P E U T I C S 03
  • 6. Cardiovascular Disease Autoimmune Disease Nephropathy Osteology Genetic Disease Infection Neurology Inflammatory Disease Ophthalmology Excessive or insufficient activation will break the delicate balance between complement activation and regulation, leading to a variety of diseases. Creative Biolabs provides a great variety of therapeutic antibodies, inhibitors, soluble complement regulators, as well as customized services to help our customer develop novel drugs for complement- related diseases. Complement Therapeutics Indication C O M P L E M E N T T H E R A P E U T I C S Complement-related Diseases Complement Therapeutics 04
  • 7. Technicians in Creative Biolabs’s experienced team provide complement therapeutic services ranging from therapeutic antibody, protease inhibitor, soluble complement regulator, complement component inhibitor to anaphylatoxin receptor antagonist development. We help our clients discover novel drugs, avoid the pitfalls of variability in assays and benefit from the efficiency and accuracy of a dedicated facility. Complement Therapeutics Service C O M P L E M E N T T H E R A P E U T I C S 05 Serine Protease Inhibitors Soluble Complement Regulators Therapeutic Antibodies Complement Component Inhibitors Anaphylatoxin Receptor Antagonists
  • 8. • C5 Antibody Development • CD46 (MCP) Antibody Development • CD59 (MIRL) Antibody Development • CD20 Antibody Development • CD55 (DAF) Antibody Development … Antibody-based therapeutics appears to be the most rapidly growing drug class against complement-related diseases. Based on the advanced technology and rich experience, Creative Biolabs offers a comprehensive service of therapeutic antibodies development for our clients. OUR THERAPEUTIC ANTIBODY DEVELOPMENT SERVICE INCLUDES: Therapeutic Antibody Development C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Service
  • 9. A natural panel of highly effective complement regulators that primarily act at the level of convertases or the terminal complement complex (TCC) can be exploited for therapeutic purposes. We have developed an advanced platform of soluble complement regulators services to support your projects. Our soluble complement regulators services can be tailor- designed to meet your specific needs and it is fast, reliable and affordable. OUR SOLUBLE COMPLEMENT REGULATOR DEVELOPMENT SERVICE INCLUDES: • sCR1/TP10 Development Service • CAB-2/MLN-2222 Development Service • C4-binding Protein (C4BP) Development Service • Factor H Development Service • Factor I Development Service … Soluble Complement Regulator Development C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Service
  • 10. Inappropriate activation or regulation of complement cascade may be destructive for host cells and is involved in lots of diseases and pathological conditions. Modulation or inhibition of complement activity has therefore been regarded as a promising diagnostic or therapeutic strategy. Creative Biolabs is proud to offer a range of complement component inhibitors development services in a timely and cost-effective manner. OUR COMPLEMENT COMPONENT INHIBITOR DEVELOPMENT SERVICE INCLUDES: • Compstain • Aptamer … Complement Component Inhibitor Development C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Service
  • 11. Complement systems are proteolytic cascades in which serine proteases are activated from each other by limited proteolysis in a strictly ordered manner. Inhibition of the complement serine proteases may be an attractive therapeutic approach. As one of the most highly respected drug discovery and antibody development companies, Creative Biolabs provides biotherapeutics development strategies for serine protease inhibitors including serpins, macroglobulins, and other small protein inhibitors. OUR SERINE PROTEASE INHIBITOR DEVELOPMENT SERVICE INCLUDES: • Serpins Development Service • Macroglobulins Development Service • Small Protein Inhibitors Development Service … Serine Protease Inhibitor Development C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Service
  • 12. Anaphylatoxins, or complement peptides, are fragments that are produced as part of the activation of the complement system. Complement protein C5a and C3a are the most common targets of inhibition against various diseases and the antagonists for C5aR and C3aR have been explored as therapeutic intervention in many diseases. Creative Biolabs provides anaphylatoxin receptor antagonist development services against a variety of complement component. OUR ANAPHYLATOXIN RECEPTOR ANTAGONIST DEVELOPMENT SERVICE INCLUDES: • PMX53 • SB290157 … Anaphylatoxin Receptor Antagonist Development C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Service
  • 13. 05 Inhibitors • High affinity • High specificity • Wide applications • High potency • Standardized transportation • Customizable … • Safe • High efficiency • Quality control • Ready to use • Universality • Customizable … • High specificity and sensitivity • Quick and accurate results • Easily automated • Convenient and easy- to-use • Low false-positive rate • Customizable … • Guaranteed quantity • Fast synthesis • High specificity • User-friendly presentation • Customizable … • High purity • High solubility • Wide applications • Mimetic function • Standardized transportation • Customizable … Complement Therapeutics Products C O M P L E M E N T T H E R A P E U T I C S 06 01 Antibodies 02 Proteins 03 Peptides 04 Assay Kits 05 Inhibitors
  • 14. Creative Biolabs offers a series of ready-to-use antibodies targeting different components of the complement system. These antibodies with good sensitivity and specificity are available for WB, Flow, Func, IA, ICC/IF, IHC, IHC-Fr. We believe that our high-quality antibodies can assist your research and development project of the complement system. Product Name Specie Reactivity Applications Anti-Complement Component C1qA Monoclonal Antibody Human WB; Flow; Func; IA; ICC/IF; IHC Anti-Complement Component C1r Monoclonal Antibody Human WB; IP Anti-Complement Component C2 Monoclonal Antibody Human WB; IP; ELISA Anti-Complement Component C3 Monoclonal Antibody Human ELISA; IF; IHC; WB Anti-Complement Component C4 Monoclonal Antibody Human ELISA; WB Anti-Complement Component C5 Monoclonal Antibody Human ELISA; WB Anti-Complement Component C6 Monoclonal Antibody Human ELISA; Flow; IHC; IHC-Fr Anti-Complement Component C7 Monoclonal Antibody Human WB; ELISA Featured antibodies for complement therapeutics: ANTIBODIES C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Products
  • 15. Creative Biolabs provides a variety of complement system-related proteins, which could be the qualified tools for the early discovery process in life science research and groundbreaking development of specific clinical applications. These proteins with high purity and solubility are available for WB, ELISA, PA, AP, etc. Product Name Applications Recombinant Human C1QB Protein-GST tag WB; ELISA; PA; AP Recombinant Mouse C1qBP Protein-6His tag Binding Activity Assays Recombinant Human Complement Component C1qC Protein-GST tag WB; ELISA; PA; AP Recombinant Human C1QL1 Protein-GST tag AP; Array; ELISA; WB Recombinant Human Complement Factor H-related 5 Protein-10His tag Bioactivity Assays Recombinant Mouse Complement Factor P Protein-His tag WB; ELISA; IP Recombinant Human Complement C3 Protein-GST tag WB; ELISA; PA; AP Featured proteins for complement therapeutics: Complement Therapeutics Products PROTEINS C O M P L E M E N T T H E R A P E U T I C S
  • 16. Creative Biolabs provides a wide range of array kits that are considered as particularly powerful tools for studying disease pathways, screening for potential drug candidates and evaluating biopharmaceutical production processes. These specific array kits can detect new receptors or targets in various diseases, assess protein-protein interactions, to quantitate the amount of target analytes or monitor protein expression levels in biological samples. Product Name Pack Size Human Complement C3a des Arg ELISA Kit 96 wells Human Complement C4a des Arg ELISA Kit 96 wells Human Complement C5a AccuSignal ELISA Kit 96 wells Human Complement C3 ELISA Kit 96 wells Human Complement C1q ELISA Kit 96 wells Human Complement C1R ELISA Kit 96 wells Human Complement C2 ELISA Kit 96 wells Featured array kits for complement therapeutics: ARRAY KITS C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Products
  • 17. Peptides are synthesized naturally from transcription of DNA and they perform a wide range of essential functions in all manner of biological processes. Creative Biolabs provides the customers with many kinds of different premade complement associated peptides, from which you can easily choose an optimal candidate to help you get a milestone development. Product Name Applications Glutamic acid decarboxylase mAb (11) Blocking Peptide IHC; WB Glutamic acid decarboxylase pAb Blocking Peptide IHC; WB Heme oxygenase 1 pAb Blocking Peptide Elisa; WB Heme oxygenase 2 pAb Blocking Peptide Elisa; WB Complement C1q Binding Protein (CD93) Peptide ELISA; WB; IP; IHC; ICC Complement C2 Blocking Peptide IHC; WB Complement C1QB Blocking Peptide Blocking Featured peptides for complement therapeutics: PEPTIDES C O M P L E M E N T T H E R A P E U T I C S Complement Therapeutics Products
  • 18. Why Us • 10 years+ of exploration & development • Full range of one-stop services for Complement Therapeutics • Fully customizable project procedure • Your best partner in Complement-based Drug Discovery Service Features • Extensive experience and advanced biotechnologies • Fully customizable experimental design to meet your R&D timeline and budget • Competitive price with the best quality • Best after-sale service 07 Our Advantages
  • 19. Contact Us USA HQ Mailing Address: 45-1 Ramsey Road, Shirley, NY 11967, USA Tel: 1-631-466-5530 Fax: 1-631-207-8356 Email: info@creative-biolabs.com Quality / Science / Dedication